Dermorphin is a naturally occurring opioid heptapeptide from South American tree frogs, investigated for mu-opioid receptor binding, pain modulation, and opioid receptor pharmacology research.
| Molecular Weight | 802.94 g/mol |
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
Science-backed research overview for this compound
Dermorphin is a naturally occurring heptapeptide (7 amino acids) first isolated from the skin of South American tree frogs. It is a highly potent opioid peptide with a unique D-amino acid in its second position, which protects it from degradation.
Dermorphin is a highly selective and potent agonist for the mu-opioid receptor. Research indicates it is many times more powerful than morphine at activating these receptors, which are responsible for pain modulation, reward pathways, and emotional regulation.
In laboratory studies, Dermorphin has shown remarkable analgesic (pain-killing) properties with minimal tolerance development compared to traditional opioids. It is a primary subject for research into next-generation pain management and the study of opioid receptor binding kinetics.